Prognostic factors in severe pulmonary hypertension patients who need parenteral prostanoid therapy: The impact of late referral

Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)

Nazzareno Galiè, Marius M. Hoeper, Marc Humbert et al. · European Heart Journal · 2009 · 3.9K citations · Full text

Medicine, Cardiology, Internal Medicine +11

Survival in Patients with Primary Pulmonary Hypertension

Gilbert E. D’Alonzo, Robyn J. Barst, Stephen M. Ayres et al. · Annals of Internal Medicine · 1991 · 3.5K citations

Medicine, Cardiology, Pulmonary Function Testing +12

Bosentan Therapy for Pulmonary Arterial Hypertension

Lewis J. Rubin, David B. Badesch, Robyn J. Barst et al. · New England Journal of Medicine · 2002 · 2.7K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

A Comparison of Continuous Intravenous Epoprostenol (Prostacyclin) with Conventional Therapy for Primary Pulmonary Hypertension

Robyn J. Barst, Lewis J. Rubin, Walker Long et al. · New England Journal of Medicine · 1996 · 2.7K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +9

Inhaled Iloprost for Severe Pulmonary Hypertension

Horst Olschewski, Gérald Simonneau, Nazzareno Galiè et al. · New England Journal of Medicine · 2002 · 1.8K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +12